ORBIMED ADVISORS LLC Q3 2023 Filing
Filed November 14, 2023
Portfolio Value
$4.7B
Holdings
122
Report Date
Q3 2023
Filing Type
13F-HR
All Holdings (122 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | RLAYRELAY THERAPEUTICS INC | 501,966 | $4.2T | 89675.53% | |
| 102 | —YS BIOPHARMA CO LTD | 4,541,422 | $3.6T | 77176.59% | |
| 103 | CUTREURCUTERA INC | 603,100 | $3.6T | 77123.99% | |
| 104 | NXTCNEXTCURE INC | 2,711,013 | $3.5T | 74289.09% | |
| 105 | EPIEURESSA PHARMA INC | 842,366 | $2.6T | 55292.09% | |
| 106 | VIGLVIGIL NEUROSCIENCE INC | 448,891 | $2.4T | 51396.47% | |
| 107 | KRTXKARUNA THERAPEUTICS INC | 14,000 | $2.4T | 50286.29% | |
| 108 | TDOCTELADOC HEALTH INC | 110,000 | $2.0T | 43438.59% | |
| 109 | CMMBCHEMOMAB THERAPEUTICS LTD | 2,241,274 | $2.0T | 42610.99% | |
| 110 | AFIBACUTUS MED INC | 2,648,386 | $1.8T | 39189.39% | |
| 111 | BCABBIOATLA INC | 1,009,279 | $1.7T | 36447.17% | |
| 112 | PHGEBIOMX INC | 4,553,489 | $1.6T | 34047.92% | |
| 113 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 1,541,000 | $1.6T | 34043.93% | |
| 114 | TARAPROTARA THERAPEUTICS INC | 772,584 | $1.3T | 27407.27% | |
| 115 | SYBXSYNLOGIC INC | 401,998 | $1.1T | 23995.72% | |
| 116 | —ELEVATION ONCOLOGY INC | 1,500,000 | $993.9B | 21112.83% | |
| 117 | HRTXHERON THERAPEUTICS INC | 802,700 | $826.8B | 17562.82% | |
| 118 | CALCCALCIMEDICA INC | 297,380 | $790.9B | 16800.24% | |
| 119 | GLTOUSDGALECTO INC | 924,788 | $665.4B | 14134.38% | |
| 120 | XNCRXENCOR INC | 19,142 | $385.7B | 8193.43% | |
| 121 | ALTALTIMMUNE INC | 100,000 | $260.0B | 5523.03% | |
| 122 | HARPUSDHARPOON THERAPEUTICS INC | 62,121 | $250.3B | 5317.99% | |
| 123 | —SINGULAR GENOMICS SYSTEMS IN | 540,697 | $206.0B | 4376.06% |
PreviousPage 2 of 2